Immunotherapy for Melanoma, Kidney, and Prostate Cancers
This information was originally presented at the NCCN 20th Annual Conference: Advancing the Standard of Cancer Care™ held in Hollywood, Florida.
This activity is designed to meet the educational needs of oncologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.
Following this activity, participants should be able to:
- List immunotherapies currently available for patients with melanoma and recognize and manage adverse effects unique to these agents
- Identify the emerging immunotherapies in kidney and lung cancers
Eric Jonasch, MD
The University of Texas MD Anderson Cancer Center
Anthony J. Olszanski, RPh, MD
Fox Chase Cancer Center
Gregory A. Otterson, MD
The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute
- 1.00 Participation
- 0.95 Nurse
- 1.00 Pharmacist
- 1.00 Physician